Dr. Melanie Jay, assistant professor at NYU Grossman School of Medicine, weighs in on the growing popularity of Type 2 diabetes medication semaglutide, more commonly known as Ozempic, Mounjaro and Wegovy, and the craze surrounding people using it as a treatment for weight loss